Current Assets Veränderung Datum
Abbott USD 23.51B 872M 2023-06
Aceragen USD 5.64M 12.23M 2023-03
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amgen USD 30.33B 18.14B 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Clal Biotechnology ILS 16.64M 4.52M 2022-12
Compugen USD 60.27M 9.13M 2023-09
CSL USD 9.26B 342.6M 2023-06
Dynavax Technologies USD 859.12M 23.45M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Grifols EUR 5.02B 210.6M 2023-09
Merck USD 31.95B 1.98B 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Pfizer USD 74.01B 665M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09



Aceragen Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.